CTRI/2021/03/032039已完成2 期
Clinical study to evaluate the safety and efficacy of Darchini (cinnamomum zeylanicum Blume) in the management of non-alcoholic fatty liver disease.
Central council for research in Unani medicine New dehli0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •USG documented grade 1 and grade 2 non-alcoholic fatty liver disease.
- •Patients with dull ache/ heaviness in the right hypochondriac region.
- •Patients with symptoms of dyspepsia and malaise.
- •BMI less than 34.9kg/metre square.
- •Patients who are willing to give consent.
排除标准
- •Alcoholic liver disease.
- •Grade 3 fatty liver disease and above.
- •Patients with cardiovascular and renal diseases.
- •Patients having focal fatty liver cirrhosis and known cases of hepatitis and other liver morbidities.
- •Patients having cholelithiasis and cholecystitis.
- •BMI greater than 34.9kg/meter square.
- •Pregnant and lactating women.
- •Patients having endocrine disorders like diabetes mellitus.
- •Patients on lipid lowering drugs/statins.
- •Patients who fail to give consent.
研究者
相似试验
已完成
不适用
To study the effect of Tab HFO-O2 in fatty individuals.CTRI/2016/07/007067Baidyanath Bhavan Pvt Ltd
招募中
2 期
Clinical study to evaluate the safety and efficacy of Lunagel 2.5 dermal fillerIRCT20190210042676N33ikan Teb Kimia CO30
进行中（未招募）
3 期
A Clinical Study to Evaluate the Safety and Efficacy of Livercure Tablets on Patients with Liver Cirrhosis.CTRI/2022/07/043725Jammi Pharmaceuticals Pvt Ltd
已完成
2 期
A study for Under eye dark circlesCTRI/2022/09/045732Transformative Learning Solutions Pvt Ltd32
进行中（未招募）
不适用
Clinical study to evaluate the efficacy and safety of Octagam® 10% in Idiopathic Thrombocytopenic Purpura in adults. - N/AEUCTR2005-003552-35-DEOctapharma AG116